| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 45.838 | 45.217 | 46.342 | 45.231 | 45.657 | 48.979 | 57.100 | 59.863 | 61.010 | 57.578 |
| Total Income - EUR | 45.847 | 45.221 | 46.344 | 45.234 | 45.659 | 48.981 | 57.107 | 60.548 | 61.018 | 57.596 |
| Total Expenses - EUR | 23.299 | 25.070 | 28.253 | 32.941 | 34.094 | 31.336 | 41.874 | 55.942 | 45.314 | 50.392 |
| Gross Profit/Loss - EUR | 22.548 | 20.151 | 18.092 | 12.293 | 11.565 | 17.645 | 15.234 | 4.605 | 15.704 | 7.204 |
| Net Profit/Loss - EUR | 21.173 | 18.794 | 16.701 | 10.936 | 10.195 | 16.918 | 14.776 | 4.012 | 15.136 | 5.725 |
| Employees | 2 | 2 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medcos Total S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 370 | 671 | 7.610 | 6.382 | 4.851 | 4.977 | 4.429 | 8.085 | 7.797 | 7.283 |
| Current Assets | 104.744 | 77.613 | 86.943 | 56.131 | 24.658 | 39.019 | 53.228 | 13.993 | 24.617 | 22.981 |
| Inventories | 258 | 456 | 853 | 567 | 4.523 | 5.866 | 4.388 | 0 | 0 | 0 |
| Receivables | 589 | 384 | 635 | 623 | 727 | 2.407 | 812 | 1.373 | 1.143 | 788 |
| Cash | 103.897 | 76.773 | 85.455 | 54.941 | 19.407 | 30.746 | 48.027 | 12.620 | 23.474 | 22.192 |
| Shareholders Funds | 103.919 | 77.118 | 48.732 | 58.774 | 25.685 | 42.116 | 55.958 | 19.587 | 30.709 | 25.555 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.196 | 1.167 | 45.820 | 3.739 | 3.824 | 1.881 | 1.699 | 2.490 | 1.705 | 4.709 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Medcos Total S.r.l.